3 Automotive Decorative Parts Maker, Industrial Chemicals Company and Pathology Labs Chain Stocks With a Strong Future Roadmap: SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs
- November 11, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs: ROE of 10.8% to 20.1% and FY22 to FY26 revenue CAGR of 7.6% to 27.0%. Prices as of 10 Nov 2026.
Quick Answer
The three auto trim, chemical and pathology stocks to watch are SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs. Their return on equity ranges from 10.8% to 20.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 27.0%. Dr. Lal PathLabs has the highest return on equity at 20.1%, while SJS Enterprises has the fastest revenue growth at 27.0% a year. Prices are based on the 10 November 2026 close, and this article is educational, not investment advice.
Auto trim, chemical and pathology stocks bring together companies with a visible plan for the years ahead. SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs cover an automotive decorative parts maker, an industrial chemicals company and a pathology labs chain.
This list covers three auto trim, chemical and pathology stocks with complete current figures: SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs. Every figure comes from the latest reported financials and the 10 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Auto Trim, Chemical and Pathology Stocks?
Auto trim, chemical and pathology stocks are listed companies that produce decorative badges, trims and surface parts for vehicles, make industrial chemicals and fertilisers, and run a large chain of pathology labs and collection centres. Their earnings depend on vehicle output, chemical and farm demand and test volumes.
Auto Trim, Chemical and Pathology Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| SJS Enterprises | 2,052.8 | 6,459 | 30.5 | 36.9 | 19.7 | 0.03 |
| Deepak Fertilisers | 1,177.3 | 14,354 | 14.6 | 33.2 | 10.8 | 0.83 |
| Dr. Lal PathLabs | 2,011.5 | 30,949 | 56.6 | 59.6 | 20.1 | 0.08 |
On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing auto trim, chemical and pathology stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in auto trim, chemical and pathology stocks can use the coming numbers to test whether growth is holding.
Why Do Auto Trim, Chemical and Pathology Stocks Have a Strong Roadmap in India?
Auto trim, chemical and pathology stocks have a strong roadmap in India because buyers preferring premium vehicle finishes, steady demand for industrial chemicals and growing use of preventive health tests keep widening the market for these companies.
- Auto trim. Buyers prefer premium vehicle finishes.
- Industrial chemicals. Mining and industry use these chemicals.
- Pathology. Doctors order more tests each year.
Why SJS Enterprises Features Among These Auto Trim, Chemical and Pathology Stocks
Among the auto trim, chemical and pathology stocks on this list, SJS Enterprises makes decorative aesthetic parts such as lenses, badges, decals and appliqués for vehicles, along with products for consumer durables.
The company has a return on equity of 19.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,459 crore. The stock trades at a P/E of 30.5, below the industry P/E of 36.9.
Revenue rose from Rs 374 crore in FY22 to Rs 973 crore in FY26, a compound annual growth rate of 27.0%. Net profit grew from Rs 55.0 crore in FY22 to Rs 172 crore in FY26, which works out to a compound annual growth rate of 32.9%. In the June 2026 quarter, revenue grew 25.3% year on year to Rs 266 crore, while net profit rose 115.0% to Rs 74.4 crore.
Roadmap: Premium finishes, electric vehicle styling and a rising number of parts per vehicle widen its addressable market. The company has also acquired overseas and domestic businesses, which deepen its product range and customer mix.
What to watch: Follow how newly acquired units are integrated and how premium finishes contribute to the mix.
Why Deepak Fertilisers Features Among These Auto Trim, Chemical and Pathology Stocks
Among the vehicle decor, fertiliser chemical and lab shares on this list, Deepak Fertilisers and Petrochemicals makes industrial chemicals such as ammonium nitrate and nitric acid for mining and industry, along with crop nutrients and fertilisers sold to farmers.
Revenue rose from Rs 7,707 crore in FY22 to Rs 11,609 crore in FY26, a compound annual growth rate of 10.8%. Net profit grew from Rs 468 crore in FY24 to Rs 739 crore in FY26, which works out to a compound annual growth rate of 25.7%.
In the June 2026 quarter, revenue grew 21.6% year on year to Rs 3,262 crore, while net profit rose 101.0% to Rs 490 crore. The company has a return on equity of 10.8%, a debt to equity ratio of 0.83 and a market capitalisation of Rs 14,354 crore. The stock trades at a P/E of 14.6, below the industry P/E of 33.2.
Roadmap: The company is expanding its chemical capacity for mining and industrial customers, which supports higher-value sales. Growing mining and infrastructure activity increases demand for its products.
What to watch: Follow mining demand, gas costs and progress on new chemical plants.
Why Dr. Lal PathLabs Features Among These Auto Trim, Chemical and Pathology Stocks
Among the three companies on this list, Dr. Lal PathLabs is one of India’s best-known diagnostics companies, operating a national reference laboratory with a hub-and-spoke network of labs, patient service centres and collection points.
In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore. Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%.
Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%. The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P/E of 56.6, below the industry P/E of 59.6.
Roadmap: Its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.
What to watch: Follow test volumes per patient and the balance between routine and specialised tests.
SJS Enterprises vs Deepak Fertilisers vs Dr. Lal PathLabs on Key Financials
The table below sets the three auto trim, chemical and pathology stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| SJS Enterprises | 374 | 973 | 27.0% | 172 | 17.7% |
| Deepak Fertilisers | 7,707 | 11,609 | 10.8% | 739 | 6.4% |
| Dr. Lal PathLabs | 2,140 | 2,864 | 7.6% | 510 | 17.8% |
Dr. Lal PathLabs posts the highest return on equity in this group at 20.1%. Deepak Fertilisers has the largest FY26 revenue at Rs 11,609 crore, and SJS Enterprises shows the fastest revenue growth with a 27.0% compound annual rate. A useful habit with auto trim, chemical and pathology stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several decorative part, nitric acid and diagnostics stocks instead of one name, which keeps a single result from deciding the outcome.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| SJS Enterprises | 212 | 266 | 25.3% |
| Deepak Fertilisers | 2,683 | 3,262 | 21.6% |
| Dr. Lal PathLabs | 698 | 830 | 18.9% |
Key Risks to Check Before Investing in Auto Trim, Chemical and Pathology Stocks
Every theme carries risks that deserve a check before any decision. For these auto trim, chemical and pathology stocks, the main points are: Long-term vehicle decor, fertiliser chemical and lab shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Production cycles. Vehicle output can vary with demand.
- Raw material and energy costs. Input prices can move margins in chemicals.
- Test volumes. Footfall and test mix can vary with seasons.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter auto trim, chemical and pathology stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Auto Trim, Chemical and Pathology Stocks
Auto trim, chemical and pathology stocks suit investors who prefer to study business strength before price moves. SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs each have a clear plan to grow. Based on the 10 November 2026 close, SJS Enterprises trades at Rs 2,052.8, Deepak Fertilisers at Rs 1,177.3 and Dr. Lal PathLabs at Rs 2,011.5. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these auto trim, chemical and pathology stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track auto trim, chemical and pathology stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are auto trim, chemical and pathology stocks?
Ans. Auto trim, chemical and pathology stocks are listed companies that produce decorative badges, trims and surface parts for vehicles, make industrial chemicals and fertilisers, and run a large chain of pathology labs and collection centres. Their earnings depend on vehicle output, chemical and farm demand and test volumes. This list looks at three of them, SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs, using reported FY22 to FY26 financials and the 10 November 2026 closing prices.
Which auto trim, chemical and pathology stocks are covered in this list?
Ans. This list covers SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs. Based on the 10 November 2026 close, SJS Enterprises traded at Rs 2,052.8, Deepak Fertilisers at Rs 1,177.3 and Dr. Lal PathLabs at Rs 2,011.5. Their return on equity ranges from 10.8% to 20.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 27.0%.
Why do auto trim, chemical and pathology stocks have a strong future roadmap in India?
Ans. Auto trim, chemical and pathology stocks have a strong roadmap in India because buyers preferring premium vehicle finishes, steady demand for industrial chemicals and growing use of preventive health tests keep widening the market for these companies. The main drivers are as follows. Auto trim. Buyers prefer premium vehicle finishes. Industrial chemicals. Mining and industry use these chemicals. Pathology. Doctors order more tests each year. Together these factors give the companies on this list a visible path for growth over the coming years.
How has SJS Enterprises performed financially?
Ans. Revenue rose from Rs 374 crore in FY22 to Rs 973 crore in FY26, a compound annual growth rate of 27.0%. Net profit grew from Rs 55.0 crore in FY22 to Rs 172 crore in FY26, which works out to a compound annual growth rate of 32.9%. In the June 2026 quarter, revenue grew 25.3% year on year to Rs 266 crore, while net profit rose 115.0% to Rs 74.4 crore. The company has a return on equity of 19.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,459 crore. The stock trades at a P/E of 30.5, below the industry P/E of 36.9. Looking ahead, premium finishes, electric vehicle styling and a rising number of parts per vehicle widen its addressable market. The company has also acquired overseas and domestic businesses, which deepen its product range and customer mix.
How has Deepak Fertilisers performed financially?
Ans. Revenue rose from Rs 7,707 crore in FY22 to Rs 11,609 crore in FY26, a compound annual growth rate of 10.8%. Net profit grew from Rs 468 crore in FY24 to Rs 739 crore in FY26, which works out to a compound annual growth rate of 25.7%. In the June 2026 quarter, revenue grew 21.6% year on year to Rs 3,262 crore, while net profit rose 101.0% to Rs 490 crore. The company has a return on equity of 10.8%, a debt to equity ratio of 0.83 and a market capitalisation of Rs 14,354 crore. The stock trades at a P/E of 14.6, below the industry P/E of 33.2. Looking ahead, the company is expanding its chemical capacity for mining and industrial customers, which supports higher-value sales. Growing mining and infrastructure activity increases demand for its products.
How has Dr. Lal PathLabs performed financially?
Ans. Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%. In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore. The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P/E of 56.6, below the industry P/E of 59.6. Looking ahead, its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.
What risks should investors check before buying auto trim, chemical and pathology stocks?
Ans. Investors should check a few risks before buying auto trim, chemical and pathology stocks. Production cycles. Vehicle output can vary with demand. Raw material and energy costs. Input prices can move margins in chemicals. Test volumes. Footfall and test mix can vary with seasons. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of auto trim, chemical and pathology stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 10 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
